The Promises and Limitations of N -Acetylcysteine as a Potentiator of First-Line and Second-Line Tuberculosis Drugs is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: AI132940
HHS | National Institutes of Health
Grant: AI026170
HHS | National Institutes of Health
Grant: AI111276
HHS | National Institutes of Health
Grant: P30CA013330
NIAID NIH HHS
Grant: R37 AI026170
NIAID NIH HHS
Grant: R21 AI132940
NIAID NIH HHS
Grant: R01 AI026170
NIAID NIH HHS
Grant: U19 AI111276
National Institutes of Health
Grant: 5R22AI026170-02
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS
National Institutes of Health
Grant: 5U19AI111276-07
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
National Institutes of Health
Grant: 3P30CA013330-39S3
Core Support for Cancer Center
FWCI
0.84
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals